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The production of reactive oxygen species (ROS) as by-
products of cellular metabolism constitutes the mechanistic 
basis of oxidative stress in living organisms. Oxidative 
stress caused by excessive levels of ROS is long established 
as a contributing or causal factor in the pathophysiology of 
many chronic and degenerative diseases, because it engen-
ders oxidative damage to the mitochondrial membrane, 
other cellular membranes, and cellular components such as 
proteins and nucleic acids.1 Therapeutic strategies to protect 
against oxidative damage are, therefore, a subject of active 
and intense scientific investigation to date, including the 
use of antioxidants.
The potential of structurally diverse phytochemicals 
found in seeds, fruits, and vegetables to afford disease pre-
vention (chemoprevention) and health promotion has been 
linked to their antioxidant action. Certain classes of phyto-
chemicals that have been shown to exhibit antioxidant action 
include polyphenols (e.g., flavonoids and bioflavonoids), 
phenolic acids, carotenoids, trienols, and so on.2 In addition 
to antioxidant action, however, many of these phytochemi-
cals exhibit other health-promoting benefits through a vari-
ety of non-antioxidant mechanisms.3 It would, therefore, 
require novel and more encompassing assays to profile the 
health benefits of phytochemicals reliably and fully. Distinct 
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Abstract
Oxidative stress induced by excessive levels of reactive oxygen species (ROS) underlies several diseases. Therapeutic 
strategies to combat oxidative damage are, therefore, a subject of intense scientific investigation to prevent and treat such 
diseases, with the use of phytochemical antioxidants, especially polyphenols, being a major part. Polyphenols, however, 
exhibit structural diversity that determines different mechanisms of antioxidant action, such as hydrogen atom transfer 
(HAT) and single-electron transfer (SET). They also suffer from inadequate in vivo bioavailability, with their antioxidant 
bioactivity governed by permeability, gut-wall and first-pass metabolism, and HAT-based ROS trapping. Unfortunately, no 
current antioxidant assay captures these multiple dimensions to be sufficiently “biorelevant,” because the assays tend to 
be unidimensional, whereas biorelevance requires integration of several inputs. Finding a method to reliably evaluate the 
antioxidant capacity of these phytochemicals, therefore, remains an unmet need. To address this deficiency, we propose 
using artificial intelligence (AI)-based machine learning (ML) to relate a polyphenol’s antioxidant action as the output 
variable to molecular descriptors (factors governing in vivo antioxidant activity) as input variables, in the context of a 
biomarker selectively produced by lipid peroxidation (a consequence of oxidative stress), for example F2-isoprostanes. 
Support vector machines, artificial neural networks, and Bayesian probabilistic learning are some key algorithms that 
could be deployed. Such a model will represent a robust predictive tool in assessing biorelevant antioxidant capacity of 
polyphenols, and thus facilitate the identification or design of antioxidant molecules. The approach will also help to fulfill 
the principles of the 3Rs (replacement, reduction, and refinement) in using animals in biomedical research.
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pharmacological actions elicited by phytochemicals that 
exhibit polypharmacology require uniquely distinct chemis-
tries as a basis for validated assay methodology.
The structural diversity of phytochemical antioxidants 
also warrants that bespoke assay methods be developed to 
profile the antioxidant potential of various classes of anti-
oxidant compounds.4 Different chemistries would usually 
be optimal for different pharmacophores because the struc-
tural details often predict the most likely underlying 
mechanism(s) of action. The proposition that the antioxi-
dant action of polyphenols is mediated through hydrogen 
atom transfer (HAT), while carotenoids act through single-
electron transfer (SET), represents a form of structure–
function relationship. The hydrophilic-lipophilic balance 
(HLB) of the compounds is also a reliable predictor of the 
most likely site(s) of action in vivo. The HLB of compounds 
relative to the details of the assay protocol (aqueous or non-
aqueous environment) could indicate the biorelevance of 
methods.5 A review of antioxidant chemical assay literature, 
therefore, concluded that there was yet no official method 
for an antioxidant assay (and perhaps, still is none), due to a 
variety of problems associated with the methodologies, 
which question the biorelevance of assay results.6
It was reported about 20 years ago that the biorelevance 
of antioxidant chemical assays is questionable because 
most of the assays are one-dimensional.7 The bioactivity of 
drugs and other xenobiotics administered orally depends on 
the bioavailability of the drugs/xenobiotics and subsequent 
drug action at the tissue or cellular level. Bioavailability is 
the rate and extent of absorption and is influenced by per-
meation through gut wall, a process that could be influenced 
by gut-wall metabolism and first-pass metabolism during 
hepatic circulation.
Three distinct dimensions can be identified in the pro-
cess of antioxidant action exhibited by, for instance, poly-
phenols in living organisms:
1. Permeability, which depends on the physicochemi-
cal properties of the compound, for example its lipo-
philicity and ionization constant8
2. Metabolism of the compound, either by gut-wall or 
first-pass metabolism during hepatic circulation. 
Metabolism typically affects the fraction of the 
compound that exists as intact molecule and thus 
affects the fraction of the dose that is absorbed.9
3. HAT to trap ROS through phenolic bond cleavage of 
polyphenols1
These three dimensions are illustrated in Figure 1.
In vitro antioxidant assays based on chemical reactions 
or cell-based methodologies are usually deficient in one or 
more of the dimensions described above, leading to biologi-
cally irrelevant assay results. There is, therefore, a critical 
need for novel methodological platforms to overcome these 
deficiencies, which, among other benefits, could improve 
the translatability of preclinical drug discovery findings.
Application of Computational  
Systems Biology for Improving 
Biorelevance of Antioxidant Assays: 
Artificial Intelligence (AI) and  
Machine Learning (ML)
Kitano described computational systems biology as a com-
bination of experimental and computational approaches to 
system-level understanding of biology.10 This strategy was 
proposed to be capable of producing biological insights and 
predictions, the type required to obtain biorelevant mea-
surement of antioxidant capacity.
In recent times, machine learning (ML), a subfield of 
artificial intelligence (AI), has been demonstrated to afford 
a useful strategy of relating a dependent variable (e.g., anti-
oxidant action of phytochemicals in a biological system) to 
several independent variables. A learned algorithm that 
emerges from rule discovery based on several observations 
can then become a predictive tool for other usage environ-
ments involving newer but related members. Such an ML 
model was recently adopted to distinguish between differ-
ent genders, ethnicities, and ages of volunteers, through 
mass spectrometry and imaging of latent fingerprint that 
was largely composed of lipids in sweat. The ML algorithm 
sorted a very large amount of chemical information pro-
vided by tandem mass spectrometry to pinpoint specific 
molecules that are different from one person to another.11
A Global Index as a Reliable  
Measure of Oxidative Damage 
(Output Variable)
In an antioxidant assay context, a proposed ML workflow is 
displayed in Figure 2. The goal is to relate the output of an 
animal model antioxidant assay to molecular descriptors, 
either experimental or calculated, that are relevant to the 
three dimensions of permeability, metabolism, and HAT. 
Several biomarkers have been investigated as indicators of 
oxidative damage in biological systems, which typically 
apply to lipids, proteins, and nucleic acids.
Measurement of Lipid Peroxidation
Several biomarkers of lipid peroxidation have been investi-
gated to monitor the status of oxidative stress in vivo, but 
they vary widely in their reliability. The relative merits of 
some key biomarkers are displayed in Table 1. F2-
isoprostanes have emerged as one of the most reliable bio-
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Figure 1. Schematic illustration showing interdependence of physicochemical properties and molecular behavior as regulators 
of antioxidant action in a biological system, and hence required input variables in a machine learning (ML) model for predicting 
biorelevant antioxidant capacity.
Figure 2. Overview of machine learning workflow for prediction of biorelevant antioxidant capacity.
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markers for assessment of oxidative stress in vivo, and 
their measurement has implicated oxidative stress in the 
pathophysiology of several diseases, as shown in Figure 
3.12 Their superiority as a biomarker is due to certain dis-
tinctive and favorable characteristics:13 (1) They are chemi-
cally stable compounds; (2) they are a specific product of 
lipid peroxidation; (3) they are produced in vivo; (4) they 
are found in detectable amounts in all normal tissues and 
biological fluids, which in turn permits definition of a nor-
mal range; (5) in animal models of oxidant injury, a sub-
stantial increase in their levels is obtained; (6) they are 
unaffected by lipid content of diet; and (7) they might pro-
vide a sensitive biochemical basis for studies aimed at dose 
optimization for antioxidants.
F2-isoprostanes are produced by non-enzymatic, free 
radical–catalyzed peroxidation of arachidonic acid. The 
measurement of F2-isoprostanes is, therefore, recognized to 
be a reliable tool to assess the status of oxidative stress in 
vivo12 and could be adapted for an antioxidant capacity 
assay. This will provide the response variable for ML.
Despite the attractiveness of isoprostanes as biomark-
ers for antioxidant assay development, their formation is 
impaired at elevated oxygen tensions, because of the 
mechanism of formation of F2-isoprostanes. The outcome 
is that their measurement as a marker of lipid peroxidation 
is insensitive in settings of elevated oxygen tension, such 
as hyperoxia-induced lung injury. Formation of isofurans 
are favored in such situations and are considered a better 
measure of lipid peroxidation.12 This fact illustrates the 
limitation of using a single biomarker to measure oxida-
tive stress.
Measurement of Oxidative Damage to Proteins
Protein oxidation results in an increase in protein carbonyl 
levels and glutamine synthetase activity.14 The protein car-
bonyls can be assayed by stable hydrazone derivatives 
formed when they react with 2,4-dinitrophenylhydrazine.15
Measurement of Oxidative Damage  
to Nucleic Acids
Oxidative damage to DNA is caused by modification in 
bases by ROS. This leads to genetic defects if the modifica-
tions are not repaired. The DNA base guanine is sensitive to 
oxidation, which makes 8-hydroxydeoxyguanosine 
(8-OHdG) a suitable biomarker for oxidative injury.16
A global index integrating measures of oxidative injury 
to lipids, proteins, and nucleic acids will give a more robust 
monitoring of oxidative damage in biological systems. It 
will also afford a better metric for evaluating the efficacy of 
phenolic antioxidants as output variables for building ML 
models. The value of a global index of oxidative damage 
was proposed in evaluating the clinical significance of bio-
markers of oxidative stress.17
ML Workflow
Molecular Descriptors (Input Variables)
The numerical indices that constitute molecular descriptors 
are either experimental or calculated metrics that define 
molecular behavior with respect to permeability, metabolism, 
Table 1. Relative Merits of Biomarkers of Lipid Peroxidation for Animal Model Antioxidant Assay Development.
No. Biomarker Production Remarks Reference
1 F2-Isoprostanes Free radical–catalyzed oxidation  
of arachidonic acid
Most reliable for assessment of 
oxidative stress in vivo
 12
2 F4- Neuroprostanes Free radical–mediated oxidation  
of docosahexaenoic acid
Reliable assessment of oxidative 
stress in neurodegenerative disease
 12
3 Malondialdehyde (MDA) Product of lipid peroxidation by a 
thiobarbituric acid reacting  
substances (TBARS) assay
MDA is an end product of peroxide 
breakdown and not a direct 
or specific product of lipid 
peroxidation, and the TBARS assay 
is not specific for MDA
 34
4 Exhaled volatile alkanes  
(e.g., ethane and pentane)
Hydrocarbon gases are minor  
end products of lipid peroxidation
Concentrations of alkanes are 
influenced by breakdown rate of 
peroxides
 34
5 Lipid hydroperoxides Product of lipid peroxidation High inconsistencies and inaccuracy 




6 D2 and E2 Isoprostanes Other products of isoprostane 
pathway, beginning with oxidation of 
arachidonic acid
Less suitable for monitoring lipid 
peroxidation because they are less 
stable than F2 isoprostanes
 13
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Figure 3. Oxidative stress as a key mechanism in the pathophysiology of several diseases. Measurement of F2-isoprostanes has 
implicated oxidative stress in the pathophysiology of several diseases affecting many target organs. This underscores the potential 
of antioxidant chemical entities as adjuncts to standard treatments, chemopreventive agents for disease prevention and health 
promotion, and candidates for novel therapeutics (see Ref.12 and references cited therein).
Figure 4. Schematic illustration of parameters (molecular descriptors) associated with each of the three dimensions governing in 
vivo antioxidant activity (biorelevant antioxidant action)—permeability, metabolism, and hydrogen atom transfer—with potential for 
use as input variables in developing a machine learning (ML)-based antioxidant capacity (AOC) assay.
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and HAT. Possible descriptors are displayed in a fishbone 
diagram in Figure 4.
Permeability of drug molecules can be measured by the 
planar artificial membrane permeability assay (PAMPA), a 
popular experimental technique with measures that are 
related to partition coefficient (Log P) and effective perme-
ability (Peff).
18 An alternative descriptor obtainable from a 
planar artificial membrane lipophilicity assay was described 
as the isocratic chromatographic hydrophobicity index 
(ICHI).19 In addition, some computational molecular 
descriptors have been shown to predict permeability. These 
include solvation-free energies, solvent-accessible surface 
area (SASA), polar surface area (PSA), and cavitation 
energies.20
The major clearance pathway of drugs is predicted by a 
rectangular method that is based on four physicochemical 
predictors: distribution coefficient (Log D), charge (cation, 
neutral, and anion), molecular weight, and protein unbound 
fraction. A support vector machine-based predictor of 
metabolism was developed to be based on renal excretion, 
cytochrome P (CYP) metabolism, and organic anion trans-
porting polypeptide (OATP).21 In addition to these, compu-
tational descriptors have been developed for predicting 
metabolism of drugs. These include reactivity descriptors 
(e.g., the calculation of Huckel charges and semi-empirical 
molecular orbital calculations) that approximate the hydro-
gen and electron abstraction processes fundamental to the 
CYP catalytic cycle. In addition, there are accessibility pre-
dictors, which could be structure-based (using docking 
approaches to insert the molecule into the CYP binding 
pocket) or ligand-based (using molecular fingerprints to 
approximate steric hindrance and orientational concerns), 
designed to complement reactivity metrics.22
The kinetics of HAT is an important rate process at the 
cellular level that distinguishes phenolic antioxidants from 
each other. Effective antioxidants can transfer hydrogen 
atoms much faster than ineffective compounds, and the pat-
tern is a function of their chemical structure. Informatics 
tools that relate the chemical structure of compounds to 
their effectiveness as antioxidants are, therefore, potentially 
useful in ML model building for antioxidant assays. A 
bespoke assay for the antioxidant action of phenolics 
adapted proton transfer kinetics modeling as a surrogate 
rate process for measuring HAT. The metric, described as 
antioxidant capacity, integrates the proton transfer reaction 
constant and the concentration of standard test solutions in 
a manner that captures the structure–function relationship. 
This is a reasonable descriptor of kinetics of phenolic bond 
cleavage.23
Density functional theory (DFT) was also applied to 
compute bond dissociation energy (BDE) and ionization 
potential (IP) as computational molecular descriptors of 
cleavage of the phenolic O–H bond,24 which could be 
adapted to ML model building.
Feature Engineering
The most challenging part of the ML workflow is, arguably, 
knowing what data to feed into the models. The main ques-
tion to be answered is “How can we find the most relevant 
data to train the models to solve the specific problem?” 
Three key considerations to identify the most relevant data 
are: (1) the right data attributes from which to infer realistic 
patterns and rules, (2) enough samples to train the model, 
and (3) engineering the data the right way (e.g., aggregate, 
integrate, transform, etc., the data) before feeding into the 
models. Feature engineering comprises feature generation 
and feature standardization. Feature generation entails 
looking at the attributes of the available data and, second, 
integrating and testing a new data source. Given the large 
number of possible molecular descriptors that represent 
potential input variables, it is a dataset without structure. 
Unsupervised learning is often used to develop a structure 
from a large dataset. Feature standardization refers to tools 
that make data “more appealing” to the model (e.g., imputa-
tion, normalization, and scaling).25
ML Algorithm Selection
A well-trained and validated ML model based on a large 
library of polyphenols could provide a predictive tool for 
evaluating the potential of newer polyphenols for effective 
antioxidant action in biological systems. ML models that 
are applied in quantitative structure–activity relationship 
(QSAR) studies and potentially useful for developing 
AI-based antioxidant assays are classified into (a) super-
vised learning, and (b) unsupervised learning. Examples of 
techniques under each of the two groups are displayed in 
Figure 5.
In supervised learning, labels are assigned to training 
data, and once trained, the model can predict labels for 
given data inputs; whereas, in unsupervised learning, the 
techniques learn underlying pattern of molecular features 
directly from unlabeled data, such as dimensionality reduc-
tion techniques (principal component analysis and indepen-
dent component analysis) and clustering algorithms. 
Clustering algorithms invariably involve (1) dividing a 
dataset by predefined distance metrics in high-dimensional 
space, and (2) assigning labels based on a number of 
observed categories.26 While unsupervised learning is par-
ticularly important for feature generation, supervised learn-
ing is more important for selection of ML algorithms.
Artificial Neural Networks (ANNs)  
and Deep Learning (DL)
The autonomous knowledge acquisition from the molecular 
properties of compounds requires the use of ML techniques 
such as k-nearest neighbor (k-NN) and artificial neural 
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networks (ANNs). An ANN is derived from the biological 
concept of neurones possessing dendrites, soma, axon, and 
synaptic dendrites. An ANN behaves as a neurone by work-
ing on three layers. The input layer takes input (like den-
drites), the hidden layer processes the input (soma and 
axon), while the output layer sends the calculated output. 
The variants of this technique are supervised, unsupervised, 
and reinforced neural networks.27 Deep learning, a branch 
of ANN that has found successful application in medicinal 
chemistry, can be described as a class of representation-
learning techniques that are able to discover, from the raw 
data, multiple-level representations of increasing complex-
ity by composing nonlinear models.28
k-NN Algorithm
The k-NN algorithm assumes that similar things exist in 
close proximity and can be used to solve both classification 
and regression problems. The algorithm works by finding 
distances between a query and all the examples in a data, 
selecting the specified number examples (k) closest to the 
query, and then voting for the most frequent label (i.e., 
mode) in the case of classification. In contrast, it votes for 
the average of the labels (i.e., mean) in the case of regres-
sion. It has a major drawback of becoming slow as the size 
of the data in use grows.29
Support Vector Machine
A support vector machine (SVM) works on the principle of 
margin calculation. Basically, margins are drawn between 
the classes in such a manner that the distance between the 
margin and the classes is maximum, hence minimizing the 
classification error.27
SVMs have gained some popularity in recent times for 
developing in silico models based on large datasets to facili-
tate the task of lead optimization in drug discovery science. 
For example, support vector regression and classification 
models were developed based on oral permeability data 
obtained from PAMPA measurement of more than 4000 
compounds in the same laboratory.18 Likewise, an in silico 
model for prediction of major clearance pathways based on 
CYP enzymes, OATP-mediated hepatic uptake, and renal 
excretion was developed and optimized, using variants of 
SVM models and more than 800 descriptors, and the model 
with feature-selected descriptors was found optimal with 
respect to predictive power.21
Bayesian Probabilistic Learning
This learning algorithm is mainly used for clustering and 
classification purposes. The underlying architecture of 
naïve Bayes depends on conditional probability. It creates 
trees, known as Bayesian networks, based on their probabil-
ity of happening.27
Random Forest
Decision trees are the types of trees that group attributes by 
sorting them based on their values. They are used mainly for 
classification purposes. Each tree is made up of nodes and 
branches. Each node represents attributes in a group that is 
to be classified, and each branch a value that the node can 
take.27 Random forest (an example of ensemble methods) 
Figure 5. Supervised and unsupervised machine learning (ML) models. ML models that are applicable in quantitative structure–
activity relationship (QSAR) studies consist of an array of techniques broadly classified as supervised and unsupervised learning.
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builds multiple decision trees and merges them to get a more 
accurate and stable prediction. An important advantage of 
random forest over simple decision trees is that it can be 
used for both regression and classification problems.30
Model Development
Input and output variables from a dataset generated from a 
training set of antioxidant polyphenols will be fed into the 
selected algorithm to construct the AI model. The predictive 
power of the model depends on the quality of feature engi-
neering, the number of compounds in the training set, and 
the performance of the selected algorithm.
Model Evaluation and Prediction
To validate the usefulness of the predictive model, a test set 
of compounds in the same chemical/biological class (e.g., 
phenolic antioxidants), which were not part of the training 
of the model, is assembled, and the predicted output is com-
pared with experimental output. The training of the model 
might go through several iterations of feature generation to 
improve the performance of the predictive model and hence 
the reliability of prediction made by AI.
Merits and Demerits of ML in 
Predicting Biological Response
The merits of machine learning consist in the array of pow-
erful techniques to explore the nonlinearity that character-
izes structure–activity relationships (SARs). The palpable 
fact is that biorelevant antioxidant capacity measurement is 
multidimensional, and a dynamic nonlinear interaction 
between the dimensions is expected in biological systems. 
This characteristic is uniquely suited for ML exploration 
because it affords a robust integration of several parameters 
associated with the various dimensions, in a nonlinear way, 
in defining a single output variable.
Deep learning has outperformed traditional techniques 
in some drug design–related applications, principally due to 
some peculiar characteristics of biological and chemical 
data, such as complexity, uncertainty, diversity, and high 
dimensionality.28
Figure 6. Chemical structures of different groups of antioxidant flavonoids (polyphenols) showing the basic structure and six major 
subclasses. (a) The pink oval highlights the structural similarity between flavonols and flavones (unsaturation in ring C). (b) The 
yellow oval highlights the structural similarity between flavanols and flavanones (saturation in ring C). (c) The green oval highlights 
the presence of an oxonium ion in the C ring of anthocyanins, which is responsible for their bright colors. (d) The blue oval highlights 
B-ring substitution at position 3 of ring C in isoflavones, instead of position 2 in flavones.
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Some drawbacks of applying ML techniques include the 
problem of overfitting of data, which is minimized by dif-
ferent strategies for different techniques. An ensemble of 
classifiers was proposed to minimize the inherent weak-
nesses of each ML technique; however, this approach gen-
erated other weaknesses like decreased comprehensibility 
of the model, increased storage, and increased computation 
requirement.31 Other drawbacks of applying deep learning 
include the limited number of data in certain areas of study 
and difficult interpretation of the chemical and biological 
mechanisms involved in deep learning models.28
Part of what is outstanding in current antioxidant 
research is to optimize the choice and dose of antioxidants 
in investigating the impact of antioxidant therapy on ame-
lioration of specific diseases. In addition to creating a global 
index, because antioxidant efficacy depends on the dose of 
the antioxidant administered, one way to incorporate this 
variable into the ML workflow (input) is to ensure the 
assays that monitor the respective biomarkers incorporate 
the dose–response curve of a well-known oxidant. The 
assay output will thus have the quality of being able to 
detect antioxidant or pro-oxidant effects of a fixed dose of 
the antioxidant. The ED50 for the model oxidant used as 
positive control will be compared with determined ED50 
after pre-treatment/treatment with the antioxidant under 
study (i.e., pre-treatment with antioxidant, followed by 
treatment with the same antioxidant in the presence of the 
oxidant). The fact that polyphenols exhibit concentration-
dependent cellular response, with their antioxidant effect 
profile typically found at relatively low concentrations 
(usually in the low micromolar range), warrants the dose 
optimization exercise for polyphenol antioxidants.23
A multidimensional assay as proposed in this perspective 
will facilitate our understanding of the clinical pharmacol-
ogy of antioxidants (Fig. 6) by integrating the bioavailability 
and biodisposition of candidate antioxidants in evaluating 
their antioxidant potential. Such a model could facilitate 
molecular design tailored to optimize bioactivity and used 
to design candidate molecules that could be useful as pow-
erful adjuncts in the treatment of diseases such as cancers 
and degenerative conditions,32 which are linked to oxidative 
stress.33
Conclusion
Artificial intelligence–based approaches such as machine 
learning hold significant promise for improving the biorel-
evance of in vitro biological assays, including antioxidant 
assays, because machine learning models will have excep-
tionally better inherent accuracy in predicting in vivo out-
comes than current in vitro assay models. Their deployment 
will also facilitate and accelerate the realization of the prin-
ciples of the 3Rs (replacement, reduction, and refinement) 
with respect to the use of animals in research.
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